384.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$379.98
Aprire:
$380.45
Volume 24 ore:
6.94M
Relative Volume:
0.81
Capitalizzazione di mercato:
$349.13B
Reddito:
$449.71B
Utile/perdita netta:
$12.81B
Rapporto P/E:
29.03
EPS:
13.2409
Flusso di cassa netto:
$19.67B
1 W Prestazione:
+3.69%
1M Prestazione:
+26.32%
6M Prestazione:
+17.40%
1 anno Prestazione:
+1.00%
Unitedhealth Group Inc Stock (UNH) Company Profile
Nome
Unitedhealth Group Inc
Settore
Industria
Telefono
1-800-328-5979
Indirizzo
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
UNH
Unitedhealth Group Inc
|
384.44 | 345.08B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
92.22 | 115.54B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
381.75 | 82.10B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
289.07 | 76.20B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
274.26 | 33.01B | 137.20B | 1.15B | 1.27B | 9.3439 |
Unitedhealth Group Inc Stock (UNH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-27 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-04-22 | Aggiornamento | Argus | Hold → Buy |
| 2026-04-07 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2026-04-01 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-07-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | Reiterato | Oppenheimer | Outperform |
| 2025-06-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | Downgrade | HSBC Securities | Hold → Reduce |
| 2025-05-19 | Downgrade | TD Cowen | Buy → Hold |
| 2025-05-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-14 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-21 | Downgrade | Argus | Buy → Hold |
| 2025-01-10 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-01-06 | Reiterato | Truist | Buy |
| 2024-10-17 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-17 | Reiterato | RBC Capital Mkts | Outperform |
| 2024-06-05 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-04 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-12-18 | Downgrade | HSBC Securities | Hold → Reduce |
| 2023-10-16 | Aggiornamento | UBS | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Reiterato | UBS | Neutral |
| 2023-07-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | Reiterato | JP Morgan | Overweight |
| 2023-07-17 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-07-17 | Reiterato | TD Cowen | Outperform |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-11-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-06-01 | Reiterato | BofA Securities | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Overweight |
| 2021-04-21 | Aggiornamento | Argus | Hold → Buy |
| 2020-10-19 | Downgrade | Argus | Buy → Hold |
| 2020-07-01 | Ripresa | SVB Leerink | Outperform |
| 2020-06-05 | Iniziato | Goldman | Buy |
| 2020-03-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2019-10-18 | Iniziato | Mizuho | Buy |
| 2019-10-10 | Downgrade | Jefferies | Buy → Hold |
| 2019-09-30 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-05-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-04-23 | Iniziato | UBS | Neutral |
| 2019-04-17 | Reiterato | BofA/Merrill | Buy |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-09-10 | Downgrade | Citigroup | Buy → Neutral |
| 2018-06-11 | Iniziato | SunTrust | Buy |
| 2018-03-08 | Iniziato | Barclays | Overweight |
| 2018-01-17 | Reiterato | Citigroup | Buy |
| 2018-01-12 | Reiterato | Evercore ISI | Outperform |
| 2018-01-03 | Iniziato | Goldman | Buy |
| 2017-07-19 | Reiterato | Mizuho | Buy |
| 2017-06-07 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Unitedhealth Group Inc Borsa (UNH) Ultime notizie
UnitedHealth to Present Strategy at Upcoming Healthcare Conference - TipRanks
UnitedHealth to Present Strategy and Results at Bank of America Health Care Conference - TradingView
UnitedHealth Group (NYSE: UNH) plans webcasted talk at Bank of America health conference - Stock Titan
UnitedHealth’s Optum Rx to shift PBM model in transparency push - Modern Healthcare
Top Research Reports for UnitedHealth, Merck & Qualcomm - Yahoo Finance Singapore
UnitedHealth Group stock (US91324P1021): Q1 earnings beat and raised FY guidance - AD HOC NEWS
UnitedHealth’s Optum Rx Says Profits Won’t Depend on Drug Prices - Bloomberg.com
UnitedHealth Group stock (US91324P1021): Q1 earnings beat and JPMorgan target hike - AD HOC NEWS
UnitedHealth Group stock (US91324P1021): Q1 earnings beat, JPMorgan raises price target - AD HOC NEWS
UnitedHealth Group stock (US91324P1021): Q1 2026 results show modest growth and margin focus - AD HOC NEWS
How UnitedHealth’s Margin Gains and Prior Authorization Cuts Could Impact UnitedHealth Group (UNH) Investors - simplywall.st
UnitedHealth Group Incorporated stock (US91324P1021): Q1 earnings beat and prior authorization cuts - AD HOC NEWS
UnitedHealth Group stock (US91324P1021): Q1 2026 earnings beat and guidance lift drive rebound - AD HOC NEWS
UnitedHealth Group (UNH) Valuation Check After Earnings Beat Guidance Lift And Prior Authorization Cuts - Yahoo Finance
UnitedHealth Stock Is Climbing Again: The Medical-Cost Bet Driving UNH Shares - TechStock²
UnitedHealth Group (UNH) Surges After Q1 2026 Earnings Beat — $564 Target in Play? - Bitget
Highmark Health names UnitedHealth executive as COO - Yahoo Finance
UnitedHealth Group (UNH) Valuation Check After Strong Q1 2026 Earnings Beat And Higher Guidance - simplywall.st
UnitedHealth Group Incorporated stock (US91324P1021): Q1 2026 revenue up 2% on pricing and pharmacy - AD HOC NEWS
UnitedHealth Group (UNH) Stock Chart and Price History 2026 $UNH - MarketBeat
Highmark Health Appoints Former UnitedHealth Executive Heather Cianfrocco as COO - Digital Health News
UnitedHealth to Eliminate Prior Authorization for 30% of Healthcare Services - Insider Monkey
The Pennant Group Seeks Deals Amid Amedisys-UnitedHealth Group Asset Integration - Hospice News
United Healthcare: Watch The Recovery In Action (NYSE:UNH) - Seeking Alpha
Is It Time To Reassess UnitedHealth Group (UNH) After Its Recent 30% Share Price Jump? - simplywall.st
Insurers caution shareholders about bad PR, AI risks, tariffs - Modern Healthcare
UNH Stock Moves Higher as UnitedHealth Cuts Prior Approval Rules and CVS Adds Cost Signal - TechStock²
Health insurance company cutting prior approval requirements for more services - AL.com
Global Healthcare Analytics Market is Predicted to Cross the USD 380 Billion Mark by 2034 | DelveInsight - GlobeNewswire Inc.
UnitedHealth shares edge lower with RSI approaching buy territory: weekly forecast - Traders Union
Live Nation Entertainment, TransDigm Group, Interactive Brokers And A Health Care Stock: CNBC's 'Final Trades' - Benzinga
UnitedHealthcare to cut prior authorization for 30% of treatments - MSN
UNH Stock Price, Quote & Chart | UNITEDHEALTH GROUP INC (NYSE:UNH) - ChartMill
UnitedHealthcare looks to reduce prior authorizations by 30% before end of 2026 - HealthExec
According to These Metrics, UnitedHealth Stock Looks Undervalued - The Globe and Mail
UnitedHealth Soars 36.9% in April, As Earnings Beat Unlocks Valuation Recovery Runway - NAI500
UnitedHealth Prior Authorization Shift And What It Could Mean For UNH Stock - Yahoo Finance
UnitedHealth Group | History, Growth, & Controversies - Britannica
Why UnitedHealth Group Stock Came Roaring Back In April - The Motley Fool
UnitedHealth Group (NYSE: UNH) Q1 2026 revenue edges up to $111.7B - Stock Titan
Highmark Health names ex-UnitedHealth exec as COO - Healthcare Dive
UnitedHealth Group Announces Earnings Release Date - Quantisnow
Highmark Health hires former UnitedHealth exec Heather Cianfrocco - Modern Healthcare
UnitedHealth Group Stock (UNH) Opinions on Q1 Earnings and Medicare Reimbursement Hike - Quiver Quantitative
UnitedHealth to remove annoying barrier for slew of medical procedures - New York Post
UNH stock gains retail attention: This UnitedHealth move could make getting treatment faster - MSN
UnitedHealthcare to cut prior authorization for 30% of services. Here's what to know. - CBS News
Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target - Yahoo Finance
UnitedHealthcare sits mid-pack in managed healthcare Quant rankings (UNH:NYSE) - Seeking Alpha
UnitedHealthcare removes prior approval requirements for 30% of healthcare services - Reuters
UNH Stock Gains Retail Attention: This UnitedHealth Move Could Make Getting Treatment Faster - Stocktwits
Unitedhealth Group Inc Azioni (UNH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):